Annual CFO
-$31.09 M
-$4.47 M-16.80%
31 December 2023
Summary:
Lumos Pharma annual cash flow from operations is currently -$31.09 million, with the most recent change of -$4.47 million (-16.80%) on 31 December 2023. During the last 3 years, it has fallen by -$1.45 million (-4.88%).LUMO Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFO
-$5.01 M
+$1.37 M+21.54%
30 September 2024
Summary:
Lumos Pharma quarterly cash flow from operations is currently -$5.01 million, with the most recent change of +$1.37 million (+21.54%) on 30 September 2024. Over the past year, it has increased by +$2.39 million (+32.29%).LUMO Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFO
-$31.67 M
+$2.81 M+8.16%
30 September 2024
Summary:
Lumos Pharma TTM cash flow from operations is currently -$31.67 million, with the most recent change of +$2.81 million (+8.16%) on 30 September 2024. Over the past year, it has dropped by -$578.00 thousand (-1.86%).LUMO TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LUMO Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | +32.3% | -1.9% |
| 3 y3 years | -4.9% | +13.8% | -6.8% |
| 5 y5 years | -242.1% | -83.2% | -248.4% |
LUMO Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | ||||||
| 5 y | 5 years | ||||||
| alltime | all time | -128.5% | -103.8% | -127.6% |
Lumos Pharma Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$5.01 M(-21.5%) | -$31.67 M(-8.2%) |
| June 2024 | - | -$6.38 M(-50.5%) | -$34.49 M(-0.9%) |
| Mar 2024 | - | -$12.89 M(+74.4%) | -$34.79 M(+11.9%) |
| Dec 2023 | -$31.09 M(+16.8%) | -$7.39 M(-5.5%) | -$31.09 M(+5.3%) |
| Sept 2023 | - | -$7.82 M(+17.0%) | -$29.53 M(+8.5%) |
| June 2023 | - | -$6.68 M(-27.3%) | -$27.23 M(-2.0%) |
| Mar 2023 | - | -$9.20 M(+57.9%) | -$27.79 M(+4.4%) |
| Dec 2022 | -$26.62 M(-10.2%) | -$5.83 M(+5.6%) | -$26.62 M(+0.1%) |
| Sept 2022 | - | -$5.52 M(-23.8%) | -$26.61 M(-5.4%) |
| June 2022 | - | -$7.25 M(-9.8%) | -$28.14 M(+3.2%) |
| Mar 2022 | - | -$8.03 M(+38.2%) | -$27.27 M(-8.0%) |
| Dec 2021 | -$29.65 M(+28.9%) | -$5.81 M(-17.5%) | -$29.65 M(-3.8%) |
| Sept 2021 | - | -$7.05 M(+10.5%) | -$30.82 M(+31.8%) |
| June 2021 | - | -$6.38 M(-38.7%) | -$23.38 M(-22.3%) |
| Mar 2021 | - | -$10.41 M(+49.2%) | -$30.10 M(+30.9%) |
| Dec 2020 | -$23.00 M(+153.0%) | -$6.98 M(-1876.1%) | -$23.00 M(+22.7%) |
| Sept 2020 | - | $393.00 K(-103.0%) | -$18.75 M(-10.8%) |
| June 2020 | - | -$13.10 M(+295.8%) | -$21.03 M(+105.9%) |
| Mar 2020 | - | -$3.31 M(+21.1%) | -$10.21 M(+12.4%) |
| Dec 2019 | -$9.09 M(-76.0%) | -$2.73 M(+44.9%) | -$9.09 M(+18.5%) |
| Sept 2019 | - | -$1.89 M(-17.5%) | -$7.67 M(-63.1%) |
| June 2019 | - | -$2.29 M(+4.5%) | -$20.80 M(-18.3%) |
| Mar 2019 | - | -$2.19 M(+66.0%) | -$25.45 M(-32.9%) |
| Dec 2018 | -$37.94 M(-21.4%) | -$1.32 M(-91.2%) | -$37.94 M(-29.5%) |
| Sept 2018 | - | -$15.01 M(+116.4%) | -$53.83 M(+17.1%) |
| June 2018 | - | -$6.94 M(-52.7%) | -$45.98 M(-7.9%) |
| Mar 2018 | - | -$14.68 M(-14.7%) | -$49.95 M(+3.5%) |
| Dec 2017 | -$48.28 M | -$17.21 M(+140.5%) | -$48.28 M(+0.4%) |
| Sept 2017 | - | -$7.16 M(-34.4%) | -$48.08 M(-11.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2017 | - | -$10.90 M(-16.2%) | -$54.15 M(-8.9%) |
| Mar 2017 | - | -$13.01 M(-23.5%) | -$59.45 M(-9.9%) |
| Dec 2016 | -$65.95 M(+173.8%) | -$17.01 M(+28.7%) | -$65.95 M(+15.1%) |
| Sept 2016 | - | -$13.22 M(-18.4%) | -$57.28 M(+12.1%) |
| June 2016 | - | -$16.21 M(-16.9%) | -$51.09 M(+23.8%) |
| Mar 2016 | - | -$19.51 M(+133.6%) | -$41.27 M(+71.3%) |
| Dec 2015 | -$24.09 M(-122.1%) | -$8.35 M(+18.9%) | -$24.09 M(-121.0%) |
| Sept 2015 | - | -$7.02 M(+9.9%) | $114.94 M(+1.3%) |
| June 2015 | - | -$6.39 M(+175.3%) | $113.46 M(+0.6%) |
| Mar 2015 | - | -$2.32 M(-101.8%) | $112.81 M(+3.4%) |
| Dec 2014 | $109.07 M(-522.4%) | $130.68 M(-1636.3%) | $109.07 M(-467.6%) |
| Sept 2014 | - | -$8.51 M(+20.9%) | -$29.67 M(+8.1%) |
| June 2014 | - | -$7.04 M(+16.0%) | -$27.44 M(+8.6%) |
| Mar 2014 | - | -$6.07 M(-24.7%) | -$25.26 M(-2.2%) |
| Dec 2013 | -$25.82 M(+26.1%) | -$8.06 M(+28.4%) | -$25.82 M(+5.7%) |
| Sept 2013 | - | -$6.28 M(+29.4%) | -$24.42 M(+13.6%) |
| June 2013 | - | -$4.85 M(-26.7%) | -$21.50 M(+0.2%) |
| Mar 2013 | - | -$6.62 M(-0.6%) | -$21.45 M(+4.8%) |
| Dec 2012 | -$20.47 M(+58.1%) | -$6.66 M(+98.2%) | -$20.47 M(+32.7%) |
| Sept 2012 | - | -$3.36 M(-30.1%) | -$15.43 M(-0.5%) |
| June 2012 | - | -$4.81 M(-14.7%) | -$15.51 M(+8.8%) |
| Mar 2012 | - | -$5.64 M(+248.4%) | -$14.25 M(+10.1%) |
| Dec 2011 | -$12.95 M(-2.4%) | -$1.62 M(-52.9%) | -$12.95 M(+14.3%) |
| Sept 2011 | - | -$3.44 M(-3.3%) | -$11.33 M(+43.6%) |
| June 2011 | - | -$3.56 M(-18.0%) | -$7.89 M(+82.0%) |
| Mar 2011 | - | -$4.34 M | -$4.34 M |
| Dec 2010 | -$13.27 M(+45.2%) | - | - |
| Dec 2009 | -$9.14 M(+2.9%) | - | - |
| Dec 2008 | -$8.88 M | - | - |
FAQ
- What is Lumos Pharma annual cash flow from operations?
- What is the all time high annual CFO for Lumos Pharma?
- What is Lumos Pharma quarterly cash flow from operations?
- What is the all time high quarterly CFO for Lumos Pharma?
- What is Lumos Pharma quarterly CFO year-on-year change?
- What is Lumos Pharma TTM cash flow from operations?
- What is the all time high TTM CFO for Lumos Pharma?
- What is Lumos Pharma TTM CFO year-on-year change?
What is Lumos Pharma annual cash flow from operations?
The current annual CFO of LUMO is -$31.09 M
What is the all time high annual CFO for Lumos Pharma?
Lumos Pharma all-time high annual cash flow from operations is $109.07 M
What is Lumos Pharma quarterly cash flow from operations?
The current quarterly CFO of LUMO is -$5.01 M
What is the all time high quarterly CFO for Lumos Pharma?
Lumos Pharma all-time high quarterly cash flow from operations is $130.68 M
What is Lumos Pharma quarterly CFO year-on-year change?
Over the past year, LUMO quarterly cash flow from operations has changed by +$2.39 M (+32.29%)
What is Lumos Pharma TTM cash flow from operations?
The current TTM CFO of LUMO is -$31.67 M
What is the all time high TTM CFO for Lumos Pharma?
Lumos Pharma all-time high TTM cash flow from operations is $114.94 M
What is Lumos Pharma TTM CFO year-on-year change?
Over the past year, LUMO TTM cash flow from operations has changed by -$578.00 K (-1.86%)